secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2025-08-08T23:59:59+00:00
Accession:  0001641172-25-022751
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix effects 1-for-10 reverse stock split effective Aug 11, 2025
------------------------------------------------------------------------

- Reverse stock split reduces outstanding shares from 7,968,868 to ~796,887.
- Effective 4:05 p.m. ET on Aug 11, 2025; split-adjusted trading begins Aug 12, 2025.
- No fractional shares issued; any fractional shares rounded up to whole number.
- Adjustments made to equity awards, warrants, and convertible securities proportionally.
- New CUSIP 63008J884; trading symbol remains NAOV on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000164117225022751/0001641172-25-022751-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000164117225022751/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-022751

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer